Entire Section

  • HLA ratio

    • PIB 3.9B.6 PIB 3.9B.6

      (1) The DFSA must determine an HLA Ratio for each Authorised Firm that it designates as a G-SIB or D-SIB.
      (2) The HLA Ratio determined under (1) for a D-SIB must be not less than 1% and not more than 3.5%.
      (3) The DFSA may vary the HLA Ratio determined under this Rule, provided that for a D-SIB the ratio as varied is within the range specified in (2).
      (4) The procedures in Schedule 3 to the Regulatory Law apply to a DFSA decision to set or vary an HLA Ratio for an Authorised Firm.
      (5) If the DFSA decides to set or vary an HLA Ratio, the Authorised Firm may refer the matter to the FMT for review.
      (6) Paragraphs (4) and (5) do not apply to a decision relating to the HLA Ratio for a G-SIB designated under PIB Rule 1.4.1.
      Derived from DFSA RM209/2017 (Made 25th October 2017). [VER30/01-18]

      • PIB 3.9B.6 Guidance

        1. The DFSA is likely to base the HLA Ratio it determines for a G-SIB on the rate specified for that G-SIB by the Financial Stability Board, in consultation with the Basel Committee. For a D-SIB, the DFSA will determine an HLA Ratio that is between 1% and 3.5% (see PIB Rule 3.9B.6(2)).
        2. The Schedule 3 procedures and the right of review by the FMT do not apply to a rate applied to a G-SIB designated under PIB Rule 1.4.1. This is because the rate specified by the DFSA for such a G-SIB will be the rate recommended by the FSB and Basel Committee.
        Derived from DFSA RM209/2017 (Made 25th October 2017). [VER30/01-18]